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We have developed an animal model to study human 
delayed-type hypersensitivity reactions occurring in 
a human environment within a mouse host. Human 
skin was grafted onto the backs and autologous hu-
man immune cells were injected into the peritoneal 
cavity of mice with severe combined immunodefi-
ciency. Seven and 14 d after grafting, 2-S0% of total 
white blood and spleen cells were of human origin. 
Mouse spleen-derived human T cells from tetanus 
toxoid-sensitized donors proliferated in response to 
tetanus toxoid as measured by [3H]thymidine uptake, 
and the strength of this proliferative response 
equaled that with pre-graft T cells &om the same 
donor. Proliferation was blocked with monoclonal 
antibodies t o h uman but not to mouse major histo-
compatibility complex antigens and with anti-human 
CD4 monoclonal antibodies. III lliuo vaccination of 
Ex perime ntal procedures to e lu cidate the pathogen es is of infl ammato ry reactio n s in h umans ill II ivo are limi ted . b y techni cal , e thical , and h ea lth-re la ted con straints. Efforts have th e re fore b een m ad e to study the human immune sys te m unde r exp erime nta l conditions ill II jlro 
o r , altem ative ly, to u se sm all animal m o d els ill IIjllo. Altho u gh th e 
info rmatio n concernin g m o lecul es and cells th at regul ate inflam-
m ato ry reac ti o n s ga ined b y thi s appro ach is con siderable , it is b ased 
o n an alogies and is th e refore n e ith e r compreh e n sive n o r entire ly 
correct. Pro ble m s ari se mainly £i'om the fac t th a t d evelo pme ntal 
difFe ren ces b e tween human s and ro d ents h ampe r a di rec t compar-
ison o f hum an and m o u se patho logy. C ertain surface receptors 
fo und in hum an s arc no t expressed in mice, and , m os t impo rtantl y, 
cer ta in human diseases arc n ot fo und in ro d e nts. W e h ave the refo re 
develo ped an anim al m od e l that o vercom es th e species barri e r b y 
using human immune ce lls and au to logo us human skin g rafte d o nto 
mice w ith severe combined immun od e fi c ien cy (SCI D) to study 
human de la yed- type hype rsen siti v ity (DT I-I ) reactio ns occurrin g in 
a hum an e n v iro nm ent w ithin a m o use h ost. 
I-Ie re we sh ow tha t human T cells g ra fted into SCID mice b y 
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mice with tetanus toxoid did not enhance prolifera-
tion of mouse spleen-derived human T cells in re-
sponse to antigen. Injection of tetanus toxoid into the 
human skin graft caused a perivascular human CD4 + / 
CD2S+ T-cell infiltrate, which was not present when 
tetanus toxoid was injected into adjacent mouse skin. 
We conclude that human T cells grafted into mice 
with severe combined immunodeficiency retain their 
function, that human T cells specifically recognize 
human but not mouse skin as homing sites, and that 
human T-cell responses depend on the human micro-
environment. This model lends itself to studies of 
endothelium-T -cell interactions, T-cell activation 
within skin, and chronic inflammatory skin diseases. 
Key words: tetaJllls/elldothelillm/ua.cci"atioll. ] Illvest Der-
matol 107:576-581, 1996 
intrape ritoneal inje ction appear in large numbe rs within the mouse 
c ircu la tion, that they re tain the ir fun c tio n in re cognizing a specific 
antigen , that they specifically recognize human but not mouse skin 
as h o ming sites , and that human T -cell respo nses in nuce de pend on 
th e human microenvironme n t. 
MATER.I ALS AND METHO DS 
Rcagcnts T etanus toxoid (TT) 5000 Limes flocculational per tnl was 
purchased from Sero Merieux (Marcy L' Eto il e, France), PI,"s""llIs 'IIIlgnri .. 
agglu tinin (PHA-L) and phorbol rnyri state ace tate were from Sigma (St. 
Loui s, MO ). 
Blocking monoclonal antibodies (M oAbs) fo r proliferation assa),s in-
cluded W 6/32 [anti-human hUlllan leukocyte antigen (HLA) class I, mouse 
IgC2a] from Seralab (Sussex , U,K.) ; Leu 3a (anti-human C D4, mouse 
IgC I) from Bec ton Dickinson (San J ose, A) ; and L243 (anti-human 
1-1 LA- D R.; mo use IgC2a) , MS/ '11 4 (anti-mo use majo r histocompatibility 
complex class II , rat IgC2b), and SF1- 1.1.1, 34-S-8S , and 30-S-7S (all 
anti-mouse m,uor hjstocompatibility complex class I, mo use IgG2a) from 
American Type Cul ture Collection (R.ockville , M D) hybridomas. Isotype 
control MoAbs were from Sigma. 
MoAbs for flu orescence-acti va ted cell so rter (FACS) and immunohisto-
chemistry included anti-human C D3, C D4, C D8, C D1 4, C D1 9, CD25, 
C D4S, CD45 R O . C D45 RA , and HLA-DR from Becton Dickinson; anti-
mo use LCA (anti-mo use C D4 S) from Endogcn (C ambridge, MA); and 
anti-mouse C D3l (Bogen et ai , 1992) a gift from S. Bogen (Department of 
Pa thology, Boston Universi ty, MA) . Isotype controls were from Sigma or 
I3ccto n Dickinson. 13iotin-conjugatcd Ulex Cllmpt'IIS agglutinin 1 ,vas fro In 
Vector (Burlingame, C Al . 
Animals Female C .B17 SCID mice (Bomitoltg,\ rd , Bomice, Denmark) 
were 5-8 wk of age when used. Mice were tested for mouse IgG by the 
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manufacturer , and IgG serum concentra tions were less tban 5 J-Lg per ml. 
The animals we re housed in micro iso la tor cages and fed ste rilized water and 
mou se chow at th e Center for Bio l11cdica l Sciences, Un ivers ity of Vicl1 n a 
Medical Sch ool. All expe rimen ts were approved by the Un iversity of 
Vienna An inla l Care and Usc COllllll ittee. 
V olunteer Donors Volunteer dono rs (n = 6) were m edica l students 
remunerated for skin and blood donation. All procedures were approved by 
a protocol (EK005/94) of the Uni ve rsity of Vienna Ethica l Committee . 
Skin Engraftmcnt (Day minus 14) Split skin sheets (500 1111l1 . 2 X 4 
cm 2 ) \vere harvested trOlll each hUll1 an vo luntee r dO llor thig h w ith a 
Goulian kn ife (16 gauge; Weck, Germany) and cut in to l -cm o pieces, thus 
providiJlg e igh t grafts. Mice were anesthetized by intraperito neal injec tion 
of x")' loz ine (3 mg per kg; Dayer , leverkllsen, Germany) and ket",nine (3 
mg pef kg; Parke Davis, Detroit. MI). After the skin was shaved, two skin 
segnlents (8 X 8 m m ) reaching down to the fascia we re exc ised from the 
back of each m o use (fo ur mice pe r donor), and defects we re immediate ly 
covered with human skin grafts and fix ed with di sposa ble stap les (3M , St-
Paul, MN). We previously demonstrated that mo use vesse ls inoscubte to 
human vessels approximately 10-14 d after skin engraftment (M urra y ct al. 
1994). 
Leukocyte Engraftment (Day 1) Four vo lunteer donors (retc rred to as 
high responders) were vaccinated w ith TT (75 S.E. Tetanlls-Adsorbat-
Imp fsto ff; Serotherapeutic Institute. Vienna , Austria) at day '14 . Two 
volunteer dono rs (referred to as low res ponders) with no history of TT 
vaccination within the last 10 Y we re left unvaccinated . At day 1. hepa-
rinized venous blood (500 m l) was withdrawn by ven ipuncture fi'o m each 
donor. Human peripheral b lood mononuclear cell s (PDMCs) were pre pared 
by density g rad ien t ccn trifugation using lympho lyte H (Cederl"ne . On-
eario, Canada) accord ing to the instru c tio ns provided by the m anufi, cturer. 
Aliquots were stored in liquid nitrogen. For prepa ratio n ofT cel ls. PDM Cs 
were mixed w ith ne uraminidase-treated (0.5 units per m l; Sigm a) sheep red 
blood ce ll s, incubated for 10 min at 37°C, centrifuged (10 mill. 400 X g). 
and incubated aga in fo r 45 min at 4°C . Erythrocyte-rosetted cells (CD2-
positive cell s), and non-erythrocyte-rosettcd cell s (E- ce ll s; B ce ll s and 
monocytes/macrophages) were separated by density gradient. Afte r sheep 
red blood cell s were lysed in lys is butFer (0 . 15 M NH.,C I, 1 111M KHCO" 
0 .1 mM N"2EDTA ill H 20, pH 7.4), erythrocyte- rosetted cell s were 
suspended in RPMI-1 690 medium , seeded in 100-lIIm Pe tri d ishes coa ted 
with fibronectin (10 J-Lg pe r m l; GIBCO. G rand Island , NY). and incubated 
for 45 m in at 37°C. R.ecovered nonadherent cel ls consisted of at least 98'X, 
pure C D2 + cell s as determined by FACS. 
In additiona l experiments, buffY coats obta ined fi'om the blood bank (n = 
10) or human spleen ce ll suspensions deri ved fi'o m spleens of cadaveri c 
organ do no rs (n = 2) were used . 
To remove m o use natura l ki ll er cell s, an ti-asia lo G Ml (50 J-Lg; Wako. 
Neuss, Germany) was injected intraperito nea ll y into SC ID mice 24 h befo re 
engraftm ent of h"man PDM Cs (10" cells), sp leen ce lls ( 10") , o r purified T 
ce lls (10") into the perito neal cavity of the mice. Wh ite blood cell s o b tai ned 
fro m each vo1un teer dO ll o r were suffi cient to reconstitute at least th ree 
mice. 
For vaccina tio n expcrinlcn ts, 30 units of TT were injected intrmBUSClI-
larly or intraperito nea ll y into SC ID mice reconstituted w ith human TT 
low-responder PJ3M Cs. Altern atively . 10" human autologous E- cells were 
incubated with 30 ullits ofTT at 37°C fo r 1 h , washed, irradiated with 3000 
rad , a nd inj ected together with auto logous T ce lls (10") in trapc ri to neally. 
Reco very of Human Cells from Mouse Blood or Spleens M o use 
periph eral blood cell s were o btain ed by retro-orbital bleed ing with hepa-
rinized g lass cap illari es. Spleen ce ll s w ere obtained by sq uashing the tiss ue 
between sterile glass sli des. and the resul ting cell suspensio n was poured 
through a 70-mm nylon filter (Falco n , J3ecton D ickinso n) . Human D cells, 
human m acrophages, and m o use spleen cells (E- ce lls) were separated from 
human T cell s by sheep red blood ce ll rosetting and plastic adhesion as 
described above. The remain ing m o use cell s within the h Ulllan T-cell 
populatio n were removed with magnetic beads. In brief, cells were 
incuba ted with MoAb Ly 5.2 (1 J-Lg per 011, anti-mo use CD45; Cederl ane, 
Ontario , Can ada) for 45 min at 4°C, rinsed. incubated w ith sheep anti-
mouse magnetic beads (50: 1 bead:cell rati o ; Dy" al, Os lo. Norwa y) for 15 
min at 4°C, and finall y separa ted w ith m agnets . 
FACS Analysis (Days 7 and 14) Afte r red blood cell lysis and blockiilg 
with normal m o use serum (1:10 ; Sigma) , ceUs we re incubated w ith 
fluoresce in isothiocyanate-co nj ugated M oAbs (anti-mouse CD45, an ti-
human CD45RA, CDS , and CD19). phycoerythrin (anti-human CD45 R O. 
CD3, CD4, and CD J4) , o r PerC P conjugates (anti-human CD45) in 
phosphate-buffe red sa line and 1 % bovin e serum album in. After the ce ll s 
were rinsed, surface antigen expressio n was quantified using a FACScan 
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F igure L NUD1bers and phenotype of human leukocytes within t h e 
SCID D10use blood and spleen. (a) Seven and 14 d after leukocyte 
eng raftm en t, numbers of human CD45 + cell s were determined by FACS 
and expressed as 111can percentages of tota l w hi te b lood cells. Error hars, 
mean ::': SD (n = 3). (I)) Four teen days afte r leukocyte engraftm ent. the 
phenotype of human CD45 + ce lls w ithin blood and spleens was determined 
by three-co lo r FACS analys is, and res u lts of two independent experiments 
fro 111 two difFeren t do no rs arc presented. 
(Becton Dickinson, M o untain View. C Al. T he numbers of hurnan CD4S + 
cell s were expressed as percentages of tota l w hite blood ce ll s. H uman 
leukocyte subpopulations were expressed as percentages of total huma n 
CD45 + cells. 
Proliferation Assays in Response to TT (Day 14) Pro li feration assays 
were performed for each do no r and fo r each mouse using pre- graft PBM Cs 
and mouse spleen-derived hUIl",n T cells or E- spleen cells 14 dafter 
engrafttll ent into SCID mice. Cell s were suspended in RPMI (GIBCO) 
containing 10'% feta l bov ine seru m (G IJ3CO), 100 wlits pen icillin per mi. 
100 J-Lg strepto m ycin pc: 1111 , and 2 111M g lutamine and placed in 96-well 
ro und-bottom plates (10 ' cell s/ well). P. 'mlgads agglu tin.in was used at 0.05 
J-Lg pe r 1111, and the concentratio n range of TT was 0 .03-300 ulli ts pe r ml. 
Blockin g M aA hs were used at a COIl cclItnl tio ll o f 10 p.g per 1111. Eac h 
treatlll ent was performed in tripli cate w e ll s. Autologous dOllor PDMCs 
irradiated w ith 3000 ra d were used as stimulato r cell s ( 10' ce ll s pCI' well). 
Afte r 5 d , [3H] thymidine (lmCi; AllIershalll, Buckinghamshire. U .K.) was 
added to each well. Cell s were harvested 12 h later o n fi lte rlna ts (Pharllla-
cia) using a semiau to mated llIu ltiwell harveste r (Wall nc , T urku. Fin land). 
dried, and placed in to plastic sample bags together with m e lt-on scintillator 
sheets (Wall ac) and m elted o n a heat sca ler (\Xla llac) . R.adioactivity was 
coun ted in a liqu id scintillat io n COu nte r (13etaplate , Wallac) and expressed 
as cpm. M eans ::': SO were calculated 1]-0111 each triplicate. 
Human Skin Grafts: Treatment and Evaluation of Infiltrating T 
Cells At da y 12, 30 units TT in 50 J-L I saline were injected .illtraderma ll )' 
into o ne human skin graft, and 50 J-L I so lvent contro l were injected in to the 
con tralate ral graft of the sa lli e anima l. In addition , TT was injected into 
nonna l 1110 1l SC skin. As a pos itive contro l, selected skin specil n c ns were 
painted w ith 5 J-Lg pho rbo l m yri state acetate. At day J 4, human skin grafts 
were harvested afte r the mice were kill ed by cervica l dis location. As a.ll 
add it.io nal control, Illllnan ski n speciincils g ra fted 011 mice 11 0 t receivi ng 
leukocyte grafts were treated iden ti ca ll y wi th TT o r sa line as described 
above. Skin infi ltrates we re eva luated o n snap-fi'ozen skin samples by a 
three-step inll11l1no hjstoch c lllistry ll1Cth od (Vcctostain ABC e li te peroxidase 
kit. Vector) as described previously (Petzc lbauer ct al. 1993). T he density of 
infi ltrating C D3 - , CD4 - , o r CD8-positi ve cell s was sco red "blind" by two 
of us. Five high-power fields (X 40 obj ective) were rand o ml y se lected in 
each section. and m ean numbers of infiltrating T ce lls were de termined. 
RESULTS 
Human Leukocytes Reconstitute within Mouse Blood and 
Spleen In mouse b lood , sing le huma n CD45 + cell s w e re d e-
tec te d as ea rl y as 2 dafte r intrapericonea l injection (data not 
sh own), and t h e numbers o f c ircu lati n g human ce ll s steadil y 
in cr eased and p eaked after appro ximate ly 14 d (Fi g 10; n = 3 in 
each g ro up at e a c h time). Because t h e p re- a dministration of 
anti-asialo GM 1 (whic h d e le t es m o u se n a tura l killer ce ll s) improved 
the reconstitution of human PBM Cs fo ur times over t h e level 
o b ser ved in mice recon stituted w ith PBMCs w ithout anti-as ia lo 
GM I (Fig 10), mice were pre - treated w ith anti-as ia lo GM l in all 
subsequent experim ents. W ithin m o u se bl ood , human CD45RO + 
578 PETZELBAUErt ET AL 
IPBMC 
H-CDt4 
F igurc 2. FACS profilcs from l1tousc blood cclls 14 d aftcr grafting 
of PBMCs, splccn cclls, or T cclls. 
cells predominated over CD45RA -I- ce ll s, whereas in m o use spl eens 
CD45RA + cells equa led or predominated over CD45RO -l- cells 
(Figs 1, 2). T he ratio ofCD4/CD8 T cells was approximately 1:1. 
When PBMCs or human spl een cell s were used for reconstitution, 
human B cells were fo und in mouse blood and spleens, but CD14 -1-
and CD16 -I- cells were always absent (Figs 1 , 2) . When T cells 
alo ne were used fo r reconstitution, leve ls of circula tin g hum an cell s 
were sign ifIcan tly lower (Fig 1), and the human CD45 -I- population 
in mouse bloo d or spleens consisted excl usively of CD3 -I- ceUs (Fig 
2) . 
Human T Cells Maintain Their Antigen Specificity TT at a 
dosage of 30 units per ml yie lded maximal prolife ratio n rates and 
was therefore used in a ll experiments. When pre-graft PBMCs 
from TT high responders were used, TT -induced proliferation rates 
were 5 to 10 times above backgro und (Fig 3a) , but when PBMCs 
from TT low respo nders were used, the rates were less than 2 times 
above b ackground (Fig 4). Prolife ration was blocked by anti-
hum an CD4, HLA-DR, and HLA class I M oAbs , the latter 
blocking activation of both CD4 -I- and CD8 + T cells by transmit-
tin g a negative signa l, as previously shown (Taylor el nl, 1986). 
An ti- m ouse major histocompa tibili ty complex class I and class /I 
M oAbs had n o elfect (Figs 3a, 4). 
Two weeks after intraperiton ea l injection of PBM Cs or T cells 
into SCID mi ce, spleens were harvested and human T ceUs were 
separated from E - cell s (mouse spleen cells and, in cases of PBM C 
reconstitution, human B cell s). As observed in pre-graft PBMCs, T 
cells cul tured in the presence of auto logous irradiated stimulato r 
cells (irradiated PBMCs) from high- but not from low-responder 
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Figurc 3. ['H]thymidinc uptake using TT high-respondcr T cclls . 
(a) Pre-graft PBMCs. Fourteen days after leukocyte engraftment, mouse 
spleen cells were separated in an E- population (mouse spleen cell s and 
human B cells without human T ce ll s: b) and human T ce lls ([). Irradiated 
ll utologous PBM Cs were used as stimulator cells. Antibody concentrations 
were 10 f-Lg per ml. Error bars. mean :!: SD of triplicate wells. PHA, 
Phaseolus vulga ri s agglu ti nin . 
donors proliferated in response to TT (Figs 3c, 4) . M oAb to human 
HLA class I and 1/ antigens and anti-human CD4 m olecules 
abrogated pro life ration in response to TT, but responses were not 
affected by Mo Abs to mouse class I and II m o lecules or by isotype 
control MoAbs (Figs 3c, 4). E- spleen cell s with or withol![ 
irradi ated PBM Cs o r T cell s without the addition of irradiated 
PBMCs did not pro life rate under the cond itio ns used (Figs 3b, 4). 
We wanted to know further whether TT responses could also be 
control 
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~ +anti-H-DR 
E 
25 +anti-H-ClassI 
o 
r<) 
+ +anti -M-ClassII 
+anti-M-ClassI'----'----
o 10000 20000 
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o T cells w/o vaccination 
111 T cells I vaccinated mouse 
Figure 4. ['H]thymidinc uptakc using TT low-respondcr T cclls. 
Pre-graft PBMCs ("alcl,ed bars); mouse spleen-deri ved human T ce lls from a 
nlouse without vacc ination (ope" bars) or frolll a vaccina ted Ill o use (intra-
peritoneal injection ofT ce ll s together with autologous irradiated stimulator 
ce lls pre-loaded with TT; jill"" liars). Fourteen days after grafting, mouse 
spleen-derived T cells were mixed with autologous irradiated stimubtor 
cells and [3H] thymidine incorporation was measured after 6 d; E'1"Or bars, 
1I1ean :!: SD of triplicate we lls. 
'1 
VOL. 107 NO. 4 OCTOBER. 1996 
- TT; wlo leukocytes-l II: 
+ TT; wlo leukocytes"'! • 
TT; T cells-
* 
+ TT; T cell s -
- TT; PBMC-
+ TT; PBMC-
a 
,.-xx-
-
x = CD4 
• = CD8 
x x 
x -- x x 
1 1 
25 50 75 
numbers of dermal cells 
100 
HPF 
Figure 5. Tetanus-induced inflammation within human skin 
grafts . Mean numbers of dermal CD4 + (x) or CDS + (e) T ce lls per 
high- power fie ld (H PF) within hllman skin grafts after intradermal injection 
of sa Ene (- TT) or TT (+ TT). Mice were reconstituted with human T ce lls 
(n = 2) or PBMCs (n = 4) frolll TT high responde rs. Controls were without 
leukocyte grafts (n = 4). 
boosted by vaccinating SCID mice with TT low-responder donor 
cells (Fig 4) . In all vaccination protocol emp loyed (i ntramuscu lar 
injection of TT, simul taneous intraperitoneal injection of TT and 
PBMCs, Or injection ofT cells together w ith irradiated, au to logous, 
and TT-Ioaded E- cell s as antigen-presenting cells), TT responses 
of mouse spleen-derived T cells were not inc reased (Fig 4), 
compared with unvaccinated controls. 
TT Injection into Human Grafts Induces a DTH Reaction 
Intraderma l inj ectio n of 30 units of TT in to hum an skin grafts on 
mice that had not received hum an le ukocytes had n o effect on 
numbers and distribution of human CD3 " and HLA-DR + ce lls 
(Fig 5). Injection of TT into human skin g rafts of mice that had 
received T cells Or PBM C grafts fi·om TT high-responder donors 
resulted in increased numbers of CD3 1-/CD4 + cell s within the 
dermis 48 h after injection compared w ith sa lin e controls (Figs 5, 
6), w hereas the numbers and distributions of ep iderma l CD3 + cells 
and d ermal mouse CD45 + cells rema ined unchanged. The presence 
of human T ce lls was a lways restri cted to t he vic ini ty of human 
endotheli al ce lls. (Fig 6; note that hum an cells are found only 
inside the human g raft and never within the adjacent mouse skin.) 
HLA-DR expression was upregula ted and CD25 -I- cells were found 
in perivascular positions in TT-injected skin sites but were absent in 
saline con tro ls (Fig 7). I In contrast, in traderm al injection of TT 
into human skin of mice reconstituted w ith cell s from TT low 
responders did not result in a sign ificant inc rease in infiltrating T 
cells within the human dermis compared to sa line con tro ls (Fig 
8e,d), but phorbol myristate acetate painting of the second human 
graft placed on the same anima l led to erythema, scaling, and T - cell 
infiltrates (Fig 8b). 
It should be noted that PBMCs, but not T - cell reconstitution, led 
to a spontaneous T-ce ll infiltra te w ithin un stimula ted human skin 
grafts (Fig 60, compare w ith Fig 8e) . We do not think that this is 
simply due to higher numbe rs of c ircul ati ng human T cells in 
PBMC- as compared w ith T - cel l-reconstitu ted mice (Fig 1a), 
because TT-induccd sIGn infiltrates w ere comparab le in both 
PBMC and T-cell mice (Fig 5) and thu s independe nt of numbers of 
circulatin g T cells. A lte rn ative ly, hum an B ce ll s that are found on ly 
in PBMC- but not in T-cell-reconstituted mice could direcriy or 
indirectl y activate T cell s, rcsulting in the spontaneous T-cell 
I Because of the small size of grafts. l1Iacroscopic criteri" of DTH 
reactions sllch as edel1la. redness, and scaling were diAicul t to score and did 
not yield sign ifica nt difFerences; therefore they were excluded from eva lu-
ation. 
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Figure 6. TT induces a predominant CD4 + T- cell infiltrate. Cryo-
stat sections of human skin grafted on an SC ID mouse 14 d after grafting of 
TT high-responder PI3MCs . .-'II,-oll's dellote the border between human (lift 
ro II", nl"rol") and mouse tissue (I"(~/II 10 ''' e nl"roll') . (n,r,c) Sa line control; (b,dJ) 
2 d after in tradermal injection of 30 lI ni ts of TT. (n ,b) Anti-CD3 . (c,d) 
anti-CD4 . and (eJ) anti-CDS sta ining. Scnle Ilnl". 0.2 mill . 
infiltrate found in PBMC mice, but underl ying mcchanism s remain 
to be e lu cidated. 
To confirm antigen specifi city of T-cell infiltrates, human skin 
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Figure 7. TT induces interleukin-2R and HLA-DR expression . 
Cryostat sections of human skin grafted on an SC ID mouse 14 dafter 
grafring of TT high-responder PBM Cs. (n,r) Saline control; (b,d) 2 dafter 
intradermal injection of 30 un its of TT. (n,b) Anri-CD25 staining: mm",,. 
indicare CD25 ' ce ll s in peri vascular position tbat arc absent in sa line 
contro \. (c,d) Anti-HLA-DR sraining: (/ITOI/'S denote tbe border bcnvecn 
Illlln a n and 1110 ll SC tiss li e. Scale bar, 0.2 1111 11 . 
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Figure 8. TT does not induce inflammation when TT low-re-
sponder T cells are used. Cryostat sections of human skin grafted onto 
SCID mice; anti-CD3 sta ining; without leukocyte graft (a) or '14 dafter 
T-ce ll grafting (TT low-responder dOllor) (b,c, d); (b) 2 d after skin painting 
with 5 f-Lg of phorbol myristate acetate; (e) sa linc contro l; (d) 2 dafter 
intradermal injection of 30 units ofTT. Scale bar, 0.2 111m. 
grafts placed on mice reconstituted with TT high responder cell s 
were inj ected with tuberculin (n = 2, data not shown). In contrast 
to TT, tuberculin did not induce perivascular CD4 '" T-cell infil-
trates. T he lack of skin inflamm ation in response to tuberculin 
correlated with the low pre-graft proliferation of donor T cells in 
response to tube rculin . To confirm tissue specificity of T-cell 
infiltra tes, TT was injected into normal mou se skin . TT did not 
indu ce human T-cell infiltrates in the mice studied (data not 
shown). 
DISCUSSION 
SCID mice have been used to study the phenotype of engrafted 
no rmal or psoriatic human skin (Yan el til, 1993; Boehncke ct til , 
1994; Nickoloff cl til, 1995), growth of melanoma ce ll s in human 
skin grafts Ouhasz cl til, 1993), and human B or T-cell functions 
(Krowka cl til, 1991; Armstrong el til, 1992; Ca rl sson el til. 1992; Lue 
e/ til , 1992; Tary-Lehmann el til, 1992; Nonoyama e/ til, 1993; 
Tary-Lehmann el til, 1994; Sandhu cl nl, 1995). In stud ies of 
combin ed human skin and PBMC grafts, human T cell s have been 
shown to induce first-set rejection of allogeneic human skin (Alegre 
el til, 1994; Murray ct nl, 1994). It has not yet been shown w hether 
th is model is also suitable to study human skin inflammatory 
reactions by combining human skin grafts with auto logous human 
T-cell grafts. 
When human T-ce ll grafts from TT -immunized donors were 
used, TT chall e nge of human skin engrafted on SCID mice was 
followed by perivascular CD4 + /CD2S '/ T-cell infiltrates . T ce lls 
recovered fi'om spleens of these mice proliferated in response to 
TT. In contra st, when T-cell grafts from TT low-responder donors 
were used. injection of TT in to human skin sites did not produce 
CD4 '" ICD25 + T-cell infiltrates, and T cells recovered from 
spleens did not proliferate in response to TT, whereas polyclonal 
T-cell activation indu ced by Phaseolus vulgaris agglutinin remained 
intact. 
In contrast to the maintenance of human T - cell reactivity to 
recall antigens in the SCID mouse environment as shown in this 
paper, Tary-Lehmann cl al (1992, 1994) demonstrated that after 
lo ng-term e ngraftment human T cells become unresponsive to 
T-cell receptor-triggered stimuli such as anti-CD3 MoAbs or reca ll 
antigens. Both the time course of experiments and the magnitude of 
injec ted human cells may account for some of the differences 
between the findings ofTaJ),-Lehmann el til and those in this study, 
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in that we e ng rafted 1 O-fold hig her numbers of cells and terminated 
experiments as e~ rly as 2 wk after engraftment. 
Migration of human T cells to skin sites in SCID mice was 
restri cted exclusively to the human tissue and, within the human 
graft, restricted to the vicinity of human endothelium. T he injec-
tion of TT into mouse skin did not even produce human T - ceil 
infiltrates, confirming the tissue specificity of endothelium-T - ceU 
interactions. Although intraderma l injection of tumor necrosis 
factor-a into human skin g rafts has been shown to induce CD62E-
dependent infiltrates of mouse neutroph.ils (Yan cl ai, 1994), we did 
not observe notable infiltrates of mouse neutrophi]s in our human 
skin specimens, except in those that became necrotic because of 
trauma or inadequate perfusion of hum~n vesse ls; these were 
excluded from further evaluation. Because ;11 JJ;JJO DTH reactions in 
humans are chara cterized by a predominant T-cell infi ltrate and 
sparse or absent neutrophils, the abse nce of mouse ne utrophils in 
o ur system may further und erscore the specifi city of the DTH 
response attra cting predominantly T ceUs, but not mouse neutro-
phils, into the les io n . 
In contrast to human B cells , which exhibit an antigen- dependent 
humoral immune response after immunization of SCID-hu mice 
with TT (Carlsson ct ai, 1992), we were unable to boost human 
T-cell responses by immunizing SCID-hu mice with TT using three 
different vaccination pathways. Intrade rmal injection of TT into 
human skin grafts, however, produced a perivascular CD4 + / 
CD2S + T-cell infiltrate, suggesting antigen-dependent activation 
of human T -cells within the human skin graft. We thus speculate 
that the ;11 JJ;JJ() indu ction of antigen-specific proli feration of human 
T ce lls in SCID mice appears to depend on the presence of human 
antigen- presenting cells in an appropriate human environment, 
which, in our experiments, was the human skin g raft. This is furth er 
supported by experiments by Krowka e/ al (1991) using SCID nuce 
in w hich human feta l thymus, li ver, and/or lymph nodes were 
transplanted . T cell s recovered £i'om these SCID m ice were found 
to be functionally competent and to proliferate in response to 
mitogens or allogeneic human cells ;11 JJ;tro even after lo ng-term 
e ngraftment (Krowka el ai, 1991) . Grafting lymphoid organs prob-
ably provided T cells with the appropriate dendritic cell population, 
together with the environment of a human lymphoid organ , to 
maintain their antigen specificity even after long-term engraftment. 
These cond itio ns were not present when peripheral mononuclear 
cells alone were used as grafts. 
We conclude that human T cell s maintain t he ir function and 
homing characteristics in SCI D mice when the en graftm ent proto-
col described here is used. T he SCID-hu mouse can therefore be 
used to study T - ce ll-endothelial cell interactions, factors governing 
T-cell activation within human skin sites, and poss ibly also chronic 
inflammatory skin diseases such as psoriasis, malignant disorders, 
e.g., cutaneo us T-cell lymphoma, or mechanisms of skin tumor 
rejection, such as of melanoma , in an ;11 JJ;JJ()-like setting. 
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tile Celltcrjar Biollledical Seiellecs oj tile Ullillcrsily (11l/ielllla Medical School Jar 
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